home / stock / lqda / lqda news


LQDA News and Press, Liquidia Technologies Inc. From 05/07/24

Stock Information

Company Name: Liquidia Technologies Inc.
Stock Symbol: LQDA
Market: NASDAQ
Website: liquidia.com

Menu

LQDA LQDA Quote LQDA Short LQDA News LQDA Articles LQDA Message Board
Get LQDA Alerts

News, Short Squeeze, Breakout and More Instantly...

LQDA - Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024

MORRISVILLE, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its first quarter 2024 financial results on May 14, 2024. The company will host a live webcast at 8:30 a.m. Eastern Time to discuss financial results and...

LQDA - (LQDA) Technical Pivots with Risk Controls

2024-05-02 17:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

LQDA - Expected US Company Earnings on Thursday, May 2nd, 2024

Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...

LQDA - Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference

MORRISVILLE, N.C., April 02, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) announced today that Dr. Roger Jeffs, Chief Executive Officer, and Micheal Kaseta, Chief Operating Officer and Chief Financial Officer, will provide an overview and update on the co...

LQDA - Buy Recommendation Issued On LQDA By Needham

2024-04-01 15:15:03 ET Needham analyst issues BUY recommendation for LQDA on April 1, 2024 02:00PM ET. The previous analyst recommendation was Buy. LQDA was trading at $14.96 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst...

LQDA - Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA(TM) (treprostinil) inhalation powder

On March 28, Judge Andrews removed the injunction issued in the Original Hatch Waxman Litigation On March 29, Judge Bates denied United Therapeutics’ motion for temporary restraining order and preliminary injunction in separate litigation filed by United Therapeutics against the FDA ...

LQDA - United Therapeutics motion for restraining order over Liquidia's Yutrepia denied

2024-03-31 08:00:00 ET More on Liquidia Liquidia Corporation (LQDA) Q4 2023 Earnings Call Transcript Liquidia Corporation: A Complicated Tale Liquidia Continues To Expand Their Growth Vs. MannKind's Growth In Share Prices Liquidia gains after court win in pat...

LQDA - Liquidia gains after court win in patent dispute with United Therapeutics

2024-03-28 16:24:45 ET Read the full article on Seeking Alpha For further details see: Liquidia gains after court win in patent dispute with United Therapeutics

LQDA - Trading (LQDA) With Integrated Risk Controls

2024-03-24 01:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

LQDA - When (LQDA) Moves Investors should Listen

2024-03-13 23:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Previous 10 Next 10